Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 7,096 | $113.07 | $802,344.72 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,908,587 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $112.53 to $113.51, inclusive. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 100 | $115.97 | $11,597.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,905,471 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 700 | $115.25 | $80,675.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,905,571 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $114.67 to $115.56, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 2,316 | $113.86 | $263,699.76 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,906,271 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $113.57 to $114.46, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 7,096 | $113.07 | $802,344.72 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,908,587 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $112.53 to $113.51, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:31 UTC |
Nixon J ScottDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000379 · edgar.xml · derivative · entry 2 Nixon J Scott · CIK 0001709352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:31 UTC |
Nixon J ScottDirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-000379 · edgar.xml · nonDerivative · entry 1 Nixon J Scott · CIK 0001709352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:30 UTC |
AUCIAUX ROBERTDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000376 · edgar.xml · derivative · entry 3 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:30 UTC |
AUCIAUX ROBERTDirector
|
Tax withholdingCommon Stock | 85 | $117.73 | $10,007.05 |
DisclosureSEC source: 0001179110-19-000376 · edgar.xml · nonDerivative · entry 2 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591 Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:30 UTC |
AUCIAUX ROBERTDirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-000376 · edgar.xml · nonDerivative · entry 1 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:31 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000378 · edgar.xml · derivative · entry 2 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% for the next four quarters. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% for the next four quarters. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:31 UTC |
FULLER GILBERT ADirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-000378 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:31 UTC |
Winssinger Frederic JDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000377 · edgar.xml · derivative · entry 2 Winssinger Frederic J · CIK 0001673356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:31 UTC |
Winssinger Frederic JDirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-000377 · edgar.xml · nonDerivative · entry 1 Winssinger Frederic J · CIK 0001673356 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:30 UTC |
Peng FengDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000375 · edgar.xml · derivative · entry 2 Peng Feng · CIK 0001673696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. F2 · derivative.expiration_date: Restricted Stock Units granted on 4/23/2018 vest 25% per quarter. Read SEC document |
| January 03, 2019 Filed Jan 4, 2019 17:30 UTC |
Peng FengDirector
|
Exercise / conversionCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-000375 · edgar.xml · nonDerivative · entry 1 Peng Feng · CIK 0001673696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 200 | $117.68 | $23,536.00 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,915,683 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $117.65 to $117.70, inclusive. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 2,600 | $117.00 | $304,200.00 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,915,883 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $116.64 to $117.61, inclusive. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 7,131 | $116.25 | $828,978.75 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,918,483 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $115.64 to $116.60, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 200 | $117.68 | $23,536.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,915,683 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $117.65 to $117.70, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 2,600 | $117.00 | $304,200.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,915,883 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $116.64 to $117.61, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 02, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 7,131 | $116.25 | $828,978.75 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,918,483 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $115.64 to $116.60, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 12, 2018 Filed Dec 13, 2018 21:32 UTC |
Peng FengDirector
|
SaleCommon Stock | 282 | $124.71 | $35,168.33 |
DisclosureSEC source: 0001179110-18-013827 · edgar.xml · nonDerivative · entry 1 Peng Feng · CIK 0001673696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 11, 2018 Filed Feb 11, 2019 21:03 UTC |
AUCIAUX ROBERTDirector
|
SaleCommon Stock | 1,000 | $120.10 | $120,100.00 |
DisclosureSEC source: 0001179110-19-001692 · edgar.xml · nonDerivative · entry 2 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,394 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 200 | $121.16 | $24,232.00 |
DisclosureSEC source: 0001144204-18-063206 · tv508529_4.xml · nonDerivative · entry 6 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,925,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 5,648 | $120.57 | $680,979.36 |
DisclosureSEC source: 0001144204-18-063206 · tv508529_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,925,814 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $120.10 to $121.09, inclusive. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 8,778 | $119.70 | $1,050,726.60 |
DisclosureSEC source: 0001144204-18-063206 · tv508529_4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,931,462 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $119.10 to $120.09, inclusive. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:01 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 200 | $121.16 | $24,232.00 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,925,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:01 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 5,648 | $120.57 | $680,979.36 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,925,814 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $120.10 to $121.09, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 11:01 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 8,778 | $119.70 | $1,050,726.60 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,931,462 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $119.10 to $120.09, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 743 | $122.72 | $91,180.96 |
DisclosureSEC source: 0001144204-18-063206 · tv508529_4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,940,240 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $122.38 to $123.00, inclusive. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 1,929 | $121.50 | $234,373.50 |
DisclosureSEC source: 0001144204-18-063206 · tv508529_4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,940,983 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $121.19 to $122.16, inclusive. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:09 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 12,702 | $120.87 | $1,535,290.74 |
DisclosureSEC source: 0001144204-18-063206 · tv508529_4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,942,912 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $120.18 to $121.17, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:01 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 743 | $122.72 | $91,180.96 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,940,240 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $122.38 to $123.00, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:01 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 1,929 | $121.50 | $234,373.50 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,940,983 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $121.19 to $122.16, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 11:01 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 12,702 | $120.87 | $1,535,290.74 |
DisclosureSEC source: 0001144204-18-063192 · tv508528_4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,942,912 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $120.18 to $121.17, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 18:33 UTC |
Guest KevinC.E.O.
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 12,183 | $0.00 Strike: $70.75 | $0.00 |
DisclosureSEC source: 0001179110-18-013352 · edgar.xml · derivative · entry 6 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 12,183 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 18:33 UTC |
Guest KevinC.E.O.
|
SaleCommon Stock | 5,059 | $121.26 | $613,471.54 |
DisclosureSEC source: 0001179110-18-013352 · edgar.xml · nonDerivative · entry 4 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,839 F3 · price: Weighted average price $121.2634. Price range in multiple transactions was $121.00 to $121.87 inclusively. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 18:33 UTC |
Guest KevinC.E.O.
|
Exercise / conversionCommon Stock | 5,059 | $70.75 | $357,898.96 |
DisclosureSEC source: 0001179110-18-013352 · edgar.xml · nonDerivative · entry 3 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| November 28, 2018 Filed Dec 3, 2018 18:33 UTC |
Guest KevinC.E.O.
|
Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 35,008 | $0.00 Strike: $70.75 | $0.00 |
DisclosureSEC source: 0001179110-18-013352 · edgar.xml · derivative · entry 5 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,183 Underlying: Common Stock · 35,008 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2018 Filed Dec 3, 2018 18:33 UTC |
Guest KevinC.E.O.
|
SaleCommon Stock | 14,369 | $120.86 | $1,736,677.57 |
DisclosureSEC source: 0001179110-18-013352 · edgar.xml · nonDerivative · entry 2 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,839 F2 · price: Weighted average price $120.8628. Price range in multiple transactions was $120.70 to $121.18 inclusively. Read SEC document |
| November 28, 2018 Filed Dec 3, 2018 18:33 UTC |
Guest KevinC.E.O.
|
Exercise / conversionCommon Stock | 14,369 | $70.75 | $1,016,534.91 |
DisclosureSEC source: 0001179110-18-013352 · edgar.xml · nonDerivative · entry 1 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 21:44 UTC |
Peng FengDirector
|
SaleCommon Stock | 282 | $120.15 | $33,882.10 |
DisclosureSEC source: 0001179110-18-013285 · edgar.xml · nonDerivative · entry 1 Peng Feng · CIK 0001673696 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 13, 2018 Filed Feb 11, 2019 21:03 UTC |
AUCIAUX ROBERTDirector
|
SaleCommon Stock | 2,500 | $119.44 | $298,590.00 |
DisclosureSEC source: 0001179110-19-001692 · edgar.xml · nonDerivative · entry 1 AUCIAUX ROBERT · CIK 0001203342 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,394 Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 17:13 UTC |
Noot WalterChief Information Officer
|
SaleCommon Stock | 363 | $119.50 | $43,378.50 |
DisclosureSEC source: 0001179110-18-012716 · edgar.xml · nonDerivative · entry 1 Noot Walter · CIK 0001691991 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 17:39 UTC |
FULLER GILBERT ADirector
|
SaleCommon Stock | 282 | $113.54 | $32,017.60 |
DisclosureSEC source: 0001179110-18-012631 · edgar.xml · nonDerivative · entry 1 FULLER GILBERT A · CIK 0001203302 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 02, 2018 Filed Nov 3, 2018 00:12 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 945 | $113.76 | $107,503.20 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,955,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $113.70 to $113.84, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 02, 2018 Filed Nov 3, 2018 00:12 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 3,591 | $113.11 | $406,178.01 |
DisclosureSEC source: 0001144204-18-057141 · tv506243_4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,956,559 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $112.69 to $113.65, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| November 02, 2018 Filed Nov 3, 2018 00:11 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 945 | $113.76 | $107,503.20 |
DisclosureSEC source: 0001144204-18-057140 · tv506242_4.xml · nonDerivative · entry 7 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,955,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $113.70 to $113.84, inclusive. Read SEC document |
| November 02, 2018 Filed Nov 3, 2018 00:11 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 3,591 | $113.11 | $406,178.01 |
DisclosureSEC source: 0001144204-18-057140 · tv506242_4.xml · nonDerivative · entry 6 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,956,559 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $112.69 to $113.65, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.